Patent details
EP3635108 Title: ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR RAAV VECTOR PRODUCTION
Basic Information
- Publication number:
- EP3635108
- PCT Application Number:
- US2018036344
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188144455
- PCT Publication Number:
- WO2018226887
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR RAAV VECTOR PRODUCTION
- French Title of Invention:
- AGENTS D'ACTIVATION DESTINÉS À LA TRANSFECTION DE CELLULES ET/OU LA PRODUCTION DE VECTEUR RAAV AMÉLIORÉES
- German Title of Invention:
- VERSTÄRKUNGSMITTEL FÜR VERBESSERTE ZELLTRANSFEKTION UND/ODER RAAV-VEKTOR-PRODUKTION
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 16/12/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 22/12/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 03/12/2025
- Unitary Effect Registration Date:
- 22/12/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/06/2018
- Grant date:
- 03/12/2025
- EP Publication Date:
- 15/04/2020
- PCT Publication Date:
- 13/12/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/12/2025
- EP B1 Publication Date:
- 03/12/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/06/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/11/2025
- Name:
- Spark Therapeutics, Inc.
- Address:
- 3737 Market Street Suite 1300, Philadelphia, Pennsylvania 19104, United States (US)
Inventor
1
- Name:
- JOSUE-ALMQVIST, Jesusa
- Address:
- United States (US)
2
- Name:
- QU, Guang
- Address:
- United States (US)
3
- Name:
- WRIGHT, John Fraser
- Address:
- United States (US)
4
- Name:
- LU, Lin
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762516432 P
- Priority Date:
- 07/06/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762531626 P
- Priority Date:
- 12/07/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 15/09; C12N 15/63; C12N 15/86; A61K 47/60; C12N 15/87;
Publication
European Patent Bulletin
1
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202604
- Publication date:
- 21/01/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202604
- Publication date:
- 21/01/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|